Juichi Fukuyama

Title: Juichi Fukuyama: Innovator in Pharmaceutical Composition

Introduction

Juichi Fukuyama is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of lipid metabolism disorders. With a total of 2 patents, his work has the potential to impact the lives of many patients suffering from related health issues.

Latest Patents

Fukuyama's latest patents include a pharmaceutical composition for the treatment of lipid metabolism disorders. This invention provides pharmaceutical compositions that contain (2S)-2-benzl-3-(cis-hexahydro-2-isoindolinylcarbonyl)propionic acid, also known as mitiglinide. These compositions are designed to prevent or treat lipid metabolism disorders, such as hyperlipidemia, particularly in diabetic patients. Another notable patent is a method for the treatment or prevention of restenosis associated with coronary intervention. This method involves administering aminobenzoic acids, specifically 2-(3,4-dimethoxy-cinnamoyl)-aminobenzoic acid, to inhibit restenosis in patients.

Career Highlights

Juichi Fukuyama is currently associated with Kissei Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective treatments that address critical health issues related to lipid metabolism.

Collaborations

Fukuyama has collaborated with notable colleagues such as Shuichiro Hamano and Arao Ujiie. These partnerships have contributed to the advancement of his research and the development of his patents.

Conclusion

Juichi Fukuyama's contributions to pharmaceutical innovations highlight his commitment to improving health outcomes for patients. His patents reflect a deep understanding of lipid metabolism disorders and the need for effective treatments.